Asset Details
Do you wish to reserve the book?
Optimising palliative care: the role of early splanchnic nerve block in advanced hepatobiliary cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Optimising palliative care: the role of early splanchnic nerve block in advanced hepatobiliary cancer
Do you wish to request the book?
Optimising palliative care: the role of early splanchnic nerve block in advanced hepatobiliary cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Optimising palliative care: the role of early splanchnic nerve block in advanced hepatobiliary cancer
2025
Overview
Patients with inoperable hepatobiliary cancers often endure severe abdominal pain, which impacts their quality of life. This pain is usually a combination of both nociceptive and neuropathic pain, which necessitates a comprehensive multimodal approach for effective management. Splanchnic nerve plexus block (SNB) has shown promising results in this regard. This case series reviews the literature and clinical practices, exploring the potential benefits of early SNB in the palliative care of patients with hepatobiliary cancers. We describe three cases illustrating SNB’s potential in achieving notable pain relief. Each patient reported a pain reduction from 10/10 to less than 1/10, a reduced requirement for opioids and sustained relief at a 1-month follow-up. This case series suggests the potential role of SNB in select patients with ongoing oncology therapy for alleviating severe pain, decreasing opioid requirements and potentially enhancing overall functional status.
